Analyst Reco. Genmab A/S

Equities

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 05/12/2025 pm IST			5-day change	1st Jan Change
2,032.00 ^DKK	-1.45%		+0.05%	+36.15%

05/12	Genmab A/S Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09:45 AM
04/12	Genmab Closes $2.5 Billion Senior Notes Offering	MT

Analyst Reco.

Kepler Cheuvreux Kicks Off Genmab Coverage at Hold	14/11	MT
Genmab advances on earnings strength and pipeline while lower valuation opens upside	07/11
Truist Trims Price Target on Genmab to $48 From $49, Keeps Buy Rating	07/11	MT
Handelsbanken raises target price for Genmab to DKK 2,200 (2,000), reiterates buy recommendation - BN	03/11	FW
Nordea Raises Price Target for Genmab to 2,021 Danish Kroner, Reiterates Buy	31/10	FW
Jyske Bank Downgrades Genmab to Hold	29/10	MT
Jyske Bank Downgrades Genmab to Hold (from Buy), Sets Target Price at 2,000 Danish Kroner - BN	28/10	FW
Goldman Sachs Raises Target Price for Genmab to 1,996 Danish Kroner, Maintains Neutral Rating - BN	24/10	FW
Genmab Shares Drop on J&J Study Data Signaling Heightened Competition	20/10	FW
Genmab A/S Announces New Data Demonstrating Investigational Rinatabart Sesutecan (Rina-S®?) Achieved Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Endometrial Cancer	18/10	CI
Aktiespararna Recommends Buying Genmab Shares	17/10	FW
GENMAB : UBS raises target price	06/10
UBS Raises Price Target for Genmab to 2,700 Danish Kroner, Reiterates Buy	06/10	FW
Deutsche Bank Raises Genmab Target Price to 2,000 Danish Kroner, Reiterates Buy	06/10	FW
Canaccord Quest Updates Buy/Sell List: Truecaller and Betsson Removed from Buys, H&M Off Sells	01/10	FW
Genmab's $8 Billion Bid Represents 'Good Deal' for Merus' Petosemtamab, Truist Says	29/09	MT
GENMAB : A bold shift from defensive to aggressive	29/09
Sydbank raises Genmab to buy (hold) - BN	29/09	FW
Ålandsbanken: Genmab Pays Too High a Price for Merus	29/09	FW
JP Morgan Raises Target Price for Genmab to 1,650 Danish Kroner (from 1,500), Maintains Neutral Rating - BN	11/09	FW
Bernstein Raises Target Price for Genmab to 1,015 Danish Kroner, Reiterates Underperform	08/09	FW
Deutsche Bank Raises Genmab Price Target to DKK 1,900, Reiterates Buy	28/08	FW
Rothschild Lowers Price Target for Genmab to 2,650 Danish Kroner (from 2,700), Reiterates Buy - BN	20/08	FW
GENMAB : target price raised by UBS	13/08
Barclays: 'Strong Quarter' for Genmab, but Short-Term Clinical Catalysts Lacking	08/08	FW

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Genmab advances on earnings strength and pipeline while lower valuation opens upside

November 07, 2025 at 08:31 pm IST

Genmab: From now on, courage to the most patient

April 01, 2025 at 08:27 pm IST